Armata Pharmaceuticals, Inc.
ARMP · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $108 | $69 | $53 | $67 |
| - Cash | $15 | $4 | $12 | $9 |
| + Debt | $114 | $111 | $135 | $127 |
| Enterprise Value | $208 | $175 | $176 | $184 |
| Revenue | $1 | $2 | $0 | $1 |
| % Growth | -46.6% | 341.8% | -60.2% | – |
| Gross Profit | $1 | $2 | $0 | $1 |
| % Margin | 68.1% | 83.1% | 23.2% | 69.2% |
| EBITDA | -$22 | -$12 | -$3 | $6 |
| % Margin | -1,894.7% | -558.8% | -519.8% | 506.9% |
| Net Income | -$27 | -$16 | -$7 | $3 |
| % Margin | -2,301.6% | -751.3% | -1,330.1% | 210.5% |
| EPS Diluted | -0.74 | -0.45 | -0.18 | 0.044 |
| % Growth | -64.4% | -150% | -509.1% | – |
| Operating Cash Flow | -$4 | -$7 | -$8 | -$8 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$5 | -$7 | -$8 | -$8 |